Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial... per Barbara E. Stähli, Catherine Gebhard, Valérie Duchatelle, Daniel Cournoyer, Thibaut Petroni, Jean‐François Tanguay, Stephen Robb, Jessica Mann, Marie‐Claude Guertin, R. Scott Wright, Philippe L. L'Allier, Jean‐Claude Tardif

Obtenir text complet